VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ARX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ARXAccelerant Holdings
$12.63$2.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksARXQuarterly Financials

Accelerant Holdings (ARX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Accelerant Holdings (ARX) quarterly income statement — complete revenue, gross profit & net income history

ARX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q1'24Q4'23
Revenue192.8M209.4M280.7M204.2M170.7M169.54M128.8M111M
Revenue Growth %12.95%23.51%--32.53%52.74%--
Medical Costs & Claims81.8M78.9M73.6M69.5M62.3M75.1M51.5M25.1M
Medical Cost Ratio %42.43%37.68%26.22%34.04%36.5%44.3%39.98%22.61%
Gross Profit111M130.5M207.1M134.7M108.4M94.44M77.3M85.9M
Gross Margin %57.57%62.32%73.78%65.96%63.5%55.7%60.02%77.39%
Gross Profit Growth %2.4%38.18%--40.23%9.94%--
Operating Expenses109M132.7M1.56B112.4M92.9M71.2M65.3M60M
OpEx / Revenue %56.54%63.37%557.39%55.04%54.42%42%50.7%54.05%
Depreciation & Amortization10M9.5M10M8.3M7.4M10.4M4.9M4M
Combined Ratio %98.96%101.05%583.61%89.08%90.92%86.29%90.68%76.67%
Operating Income2M-2.2M-1.36B22.3M15.5M23.24M12M25.9M
Operating Margin %1.04%-1.05%-483.61%10.92%9.08%13.71%9.32%23.33%
Operating Income Growth %-87.1%-109.47%--29.17%-10.27%--
EBITDA12M7.3M-1.35B30.6M22.9M33.64M16.9M29.9M
EBITDA Margin %6.22%3.49%-480.05%14.99%13.42%19.84%13.12%26.94%
Interest Expense2.5M30.9M16.2M6.9M4.2M1.5M3M0
Non-Operating Income-2.5M-30.9M-16.2M-6.9M-4.2M-1.5M-3M18.7M
Pretax Income2M-2.2M-1.36B22.3M15.5M23.24M12M-3.9M
Pretax Margin %1.04%-1.05%-483.61%10.92%9.08%13.71%9.32%-3.51%
Income Tax6.1M-3.1M9.5M9.2M7.7M2.4M9.9M6.5M
Effective Tax Rate %305%140.91%-0.7%41.26%49.68%10.33%82.5%-166.67%
Net Income-5.2M-600K-1.37B8.8M6.5M21M7.1M-2.8M
Net Margin %-2.7%-0.29%-487.64%4.31%3.81%12.39%5.51%-2.52%
Net Income Growth %-180%-102.86%---8.45%850%--
EPS (Diluted)-0.02-0.00-6.990.040.030.100.04-0.01
EPS Growth %-178%-102.79%---25%763.7%--
EPS (Basic)-0.02-0.00-6.990.040.040.130.04-0.02
Diluted Shares Outstanding221.98M221.82M206.06M219.99M216.67M216.67M177.5M191.14M